The global cancer biomarkers market size was valued at USD 18.94 billion in 2018 and is expected to grow to USD 97.42 billion by 2032, registering a compound annual growth rate (CAGR) of 12.4% over the forecast period.
Cancer Biomarkers Market Future Scope in Immunotherapy and Early Detection Tools
The global cancer biomarkers market size was valued at USD 18.94 billion in 2018 and is expected to grow to USD 97.42 billion by 2032, registering a compound annual growth rate (CAGR) of 12.4% over the forecast period.